
Sign up to save your podcasts
Or


What if children with cancer were never an afterthought in drug development again? A new federal law is changing the future of pediatric cancer research and families are leading the charge. On February 3, 2026, the Mikaela Naylon Give Kids a Chance Act was signed into law, strengthening FDA authority to require pediatric studies for certain cancer drugs. For the first time, children are no longer an afterthought in targeted therapy approvals. This episode of People Are Saying feutures Dr. Asher Marks, Dr. Vidya Puthenpura, and Mairead Finn of the Vivienne C. Finn Foundation talking about the legacy of Vivienne Finn and the growing movement to transform pediatric cancer care through research, policy, and advocacy. https://vcfinnfoundation.org/
By Sue Moretti BodsonWhat if children with cancer were never an afterthought in drug development again? A new federal law is changing the future of pediatric cancer research and families are leading the charge. On February 3, 2026, the Mikaela Naylon Give Kids a Chance Act was signed into law, strengthening FDA authority to require pediatric studies for certain cancer drugs. For the first time, children are no longer an afterthought in targeted therapy approvals. This episode of People Are Saying feutures Dr. Asher Marks, Dr. Vidya Puthenpura, and Mairead Finn of the Vivienne C. Finn Foundation talking about the legacy of Vivienne Finn and the growing movement to transform pediatric cancer care through research, policy, and advocacy. https://vcfinnfoundation.org/